Home › Funds › Morgan Stanley › BIO
Morgan Stanley position in BIO
BIO RAD LABS INC · Industrials
Latest position (Q2 2026)190.28K sh
Reported value held$55.87M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 70.92K | $52.91M | New |
| Q4 2021 | 115.12K | $86.98M | Add |
| Q1 2022 | 66.23K | $37.30M | Reduce |
| Q2 2022 | 143.01K | $70.79M | Add |
| Q3 2022 | 137.63K | $57.41M | Reduce |
| Q4 2022 | 191.12K | $80.36M | Add |
| Q1 2023 | 194.22K | $93.03M | Add |
| Q2 2023 | 199.48K | $75.63M | Add |
| Q3 2023 | 213.89K | $76.67M | Add |
| Q4 2023 | 250.07K | $80.75M | Add |
| Q1 2024 | 252.34K | $87.28M | Add |
| Q2 2024 | 217.02K | $59.27M | Reduce |
| Q3 2024 | 186.95K | $62.55M | Reduce |
| Q4 2024 | 248.29K | $81.56M | Add |
| Q1 2025 | 196.62K | $47.89M | Reduce |
| Q2 2025 | 170.10K | $41.05M | Reduce |
| Q3 2025 | 174.06K | $48.81M | Add |
| Q4 2025 | 186.39K | $56.47M | Add |
| Q1 2026 | 273.93K | $76.36M | Add |
| Q2 2026 | 190.28K | $55.87M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BIO
- First Eagle Investment Management 2.61M sh · $765.21M · Q2 2026
- Vanguard Group 1.77M sh · $537.58M · Q4 2025
- BlackRock Inc 1.70M sh · $498.82M · Q2 2026
- Bank of America Corp 490.41K sh · $143.99M · Q2 2026
- Capital World Investors 462.46K sh · $135.78M · Q2 2026
- Capital Research Global Investors 443.48K sh · $130.21M · Q2 2026
- Geode Capital Management 347.57K sh · $102.08M · Q2 2026
- UBS Group AG 308.32K sh · $90.53M · Q2 2026
- Northern Trust Corp 218.28K sh · $64.09M · Q2 2026
- Charles Schwab Investment Management 195.54K sh · $57.41M · Q2 2026
- Franklin Resources 193.68K sh · $56.87M · Q2 2026
- AQR Capital Management 192.71K sh · $56.05M · Q2 2026